1. The Role of ATRA, Natural Ligand of Retinoic Acid Receptors, on EMT-Related Proteins in Breast Cancer: Minireview
    Pavel Bobal et al, 2021, International Journal of Molecular Sciences CrossRef
  2. Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics
    D. Flodrova et al, 2017, Toxicology Letters CrossRef
  3. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts
    Raoud Marayati et al, 2021, Translational Oncology CrossRef
  4. An Updated Comprehensive Review on Vitamin A and Carotenoids in Breast Cancer: Mechanisms, Genetics, Assessment, Current Evidence, and Future Clinical Implications
    Jee Ah Kim et al, 2021, Nutrients CrossRef
  5. Pan-cancer Analysis Confirms the Prognostic and Immunological Effects of Prostate Tumor Overexpressed-1 in Human Cancers
    Fashun Liu et al, 2024, Current Cancer Drug Targets CrossRef
  6. The role of prostate tumor overexpressed 1 in cancer progression
    Verónica Cánovas et al, 2017, Oncotarget CrossRef
  7. Effects of polyclonal activators on cell differentiation and cytokine production of cultured invasive breast carcinoma of no special type, their association with tumour histopathological parameters and lymph node metastasis
    Alexander Autenshlyus et al, 2020, International Journal of Immunopathology and Pharmacology CrossRef
  8. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion
    Junhee Park et al, 2019, Journal of Clinical Investigation CrossRef
  9. Antioxidants in brain tumors: current therapeutic significance and future prospects
    Xuchen Qi et al, 2022, Molecular Cancer CrossRef
  10. Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy
    Mohamed R. Abdelaal et al, 2021, Molecules CrossRef
  11. ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells
    Akira Hirota et al, 2022, Cancers CrossRef